Management of osteoporosis at a primary care centre;Abordaje de la osteoporosis en un centro de atención primaria

Atencion Primaria

Volumn 33, Issue 4, 2004, Pages 183-187

  Zwart Salmerón, Marta ^a,c   Fradera Vilalta, M ^a   Solanas Saura, P ^b   Gonzalez Pastor C ^b   Adalid Vilar, C ^b  

^a rea B sica de Salut SALT 1   (Spain)

^b Grp Trabajo semFYC Atencion Mujeres   (Spain)

^c NONE   (Spain)

Author keywords

Guide; Osteoporosis; Primary care

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; ARTICLE; CALCIUM INTAKE; DENSITOMETRY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY HEALTH CARE; RISK FACTOR; SPAIN;

EID: 2342622785     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058768     Document Type: Article

References (15)

1. Cranney A, Coyle D, Pharn BA, Tetroe J, Wells G, Jolly E, et al. The psychometric properties of patient preferences in osteoporosis. J Rheumatol 2001;28:132-7.
2. Díaz Curiel M, García JJ, Pérez Cano R, Rapado A, Álvarez Sanz C. Prevalence of osteopenia in spanish female population. European Congress on Osteoporosis (abstract book). Osteoporos Int 1998;8(Suppl 3):S66.
3. Kenobel H, Díez A, Arnau D, Alíer A, Ibáñez J, Campodarve I. Secuelas de la fractura osteoporótica de fémur en Barcelona. Med Clin (Barc) 1992;98:441-4.
4. Liberman VA, Weiss SR, Broll J. Effect of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-43.
5. Bush TI, Wells HB, James MK. Effects of hormone therapy on bone mineral density: results from the PEPI trial. JAMA 1996;276:1389-96.
6. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-40.
7. The Swedish Council On Technology Assessment In Health Care (SBU). Bone density measurement: a systematic review. J Intern Med 1997;241(Suppl 739):
8. McClung MR. Clinical risk factors and evaluation of the risk of osteoporosis in clinical practice. Ann Med Intern 2000;151: 392-8.
9. Taggart H. Audit in osteoporosis. Osteoporosis Int 1996;2:S28-9.
10. Romagnoli E, Colangeli I, Minisola S. Awareness, attitudes and opinions on osteoporosis of primary care physicians working in the metropolitan area of Rome: a brief report. Aging (Milano) 2000;12:240.
11. Papa LJ, Weber BE. Physician characteristics associated with the use of bone densitometry. J Gen Intern Med 1997;12:781-3.
12. Stock JL, Waud CE, Coderre JA, Overdorf JH, Janikas JS, Heiniluoma KM, et al. Clinica reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial. Ann Intern Med 1998;128:996-9.
13. Espallagues M, Estrada MD, Sola M, Sampietro-Colom L, Del Río L, Granados A. Guia per a la indicació de la densitometria òssia en la valoració del risc de fractura. Agència d'Avaluació de Tecnologia Mèdica. Servei Català de la Salut. Departament de Sanitat i Seguretat Social. Generalitat de Catalunya. BR99005. Juny 1999.
14. Grupo Osteoporosis De La SEMFYC. Osteoporosis. Guía de abordaje. Recomendaciones SEMFYC. Barcelona: EdiDe, 2000.
15. Aragonès R, Orozco P. Grupo de Osteoporosis Societat Catalana de Medicina. Abordaje de la osteoporosis en la atención primaria en España (estudio ABOPAP-2000). Aten Primaria 2002;30:350-6.